TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Montelukast Intermediate Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
4 Application Overview
4.1 Introduction
4.1.1 Market Size & Forecast
4.2 Asthma
4.3 Bronchospasm
4.4 Allergic Rhinitis
4.5 Urticaria
5 End user Overview
5.1 Introduction
5.1.1 Market Size & Forecast
5.2 Pharmaceutical & Biotechnological Companies
5.3 Laboratories
5.4 Others
6 Regional Overview
6.1 Introduction
6.1.1 Market Size & Forecast
6.2 America
6.2.1 North America
6.2.1.1 U.S.
6.2.1.1.1 By Application
6.2.1.1.2 By End user
6.2.1.2 Canada
6.2.1.2.1 By Application
6.2.1.2.2 By End user
6.2.1.3 Mexico
6.2.1.3.1 By Application
6.2.1.3.2 By End user
6.2.2 South America
6.2.2.1 By Application
6.2.2.2 By End user
6.3 Europe
6.3.1 Market Size & Forecast (Value)
6.3.2 Western Europe
6.3.2.1 Germany
6.3.2.1.1 By Application
6.3.2.1.2 By End User
6.3.2.2 France
6.3.2.2.1 By Application
6.3.2.2.2 By End User
6.3.2.3 U.K.
6.3.2.3.1 By Application
6.3.2.3.2 By End User
6.3.2.4 Italy
6.3.2.4.1 By Application
6.3.2.4.2 By End User
6.3.2.5 Spain
6.3.2.5.1 By Application
6.3.2.5.2 By End User
6.3.2.6 Rest of Western Europe
6.3.2.6.1 By Application
6.3.2.6.2 By End User
6.3.3 Eastern Europe
6.4 Asia Pacific
6.4.1 Market Size & Forecast (Value)
6.4.2 China
6.4.2.1 By Application
6.4.2.2 By End User
6.4.3 India
6.4.3.1 By Application
6.4.3.2 By End User
6.4.4 Japan
6.4.4.1 By Application
6.4.4.2 By End User
6.4.5 South Korea
6.4.5.1 By Application
6.4.5.2 By End User
6.4.6 Australia
6.4.6.1 By Application
6.4.6.2 By End User
6.4.7 Rest of Asia-Pacific
6.4.7.1 By Application
6.4.7.2 By End User
6.5 Middle East & Africa
6.5.1 Market Size & Forecast (Value)
6.5.2 The Middle East
6.5.2.1 South Africa
6.5.2.1.1 By Application
6.5.2.1.2 By End User
6.5.2.2 UAE
6.5.2.2.1 By Application
6.5.2.2.2 By End User
6.5.2.3 Qatar
6.5.2.3.1 By Application
6.5.2.3.2 By End User
6.5.2.4 Rest of Middle East
6.5.2.4.1 By Application
6.5.2.4 2 By End User
7 Company Profile
7.1 ORTIN LABORATORIES LIMITED
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Product Portfolio
7.2 MANUS AKTTEVA
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Product Portfolio
7.3 P.G.Shah & Co.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Product Portfolio
7.4 VIVAN Life Sciences
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Product Portfolio
7.5 Arch Pharmalabs
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Product Portfolio
7.6 Admiron Life Sciences Pvt Ltd.
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Product Portfolio
7.7 Zhejiang Tianyu Pharmaceutical Co. Ltd.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Product Portfolio
7.8 Actis Generics Pvt Ltd.
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Recent Developments
7.8.4 Product Portfolio
